blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1413291

EP1413291 - Use of 5-Cholesten-3 beta,25-diol-7-one for the treatment of dry skin or scalp [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.03.2007
Database last updated on 29.06.2024
Most recent event   Tooltip14.08.2009Lapse of the patent in a contracting state
New state(s): BE
published on 16.09.2009  [2009/38]
Applicant(s)For all designated states
L'Oréal
14, rue Royale
75008 Paris / FR
[N/P]
Former [2004/18]For all designated states
L'OREAL
14, rue Royale
75008 Paris / FR
Inventor(s)01 / Dalko, Maria
16, Résidence du Château de Courcelles
91190 Gif S/Yvette / FR
02 / Cavezza, Alexandre
40, avenue Nelson Mandela
93290 Tremblay-en-France / FR
 [2004/18]
Representative(s)Kromer, Christophe
L'Oréal
Service DIPI
9 Rue Pierre Dreyfus
92110 Clichy / FR
[N/P]
Former [2005/41]Kromer, Christophe
L'OREAL - D.I.P.I. 25-29 Quai Aulagnier
92600 Asnières / FR
Former [2004/18]Renard, Emmanuelle
L'OREAL - D.I.P.I. 25-29 Quai Aulagnier
92600 Asnières / FR
Application number, filing date03292514.110.10.2003
[2004/18]
Priority number, dateFR2002001333924.10.2002         Original published format: FR 0213339
[2004/18]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP1413291
Date:28.04.2004
Language:FR
[2004/18]
Type: B1 Patent specification 
No.:EP1413291
Date:03.05.2006
Language:FR
[2006/18]
Search report(s)(Supplementary) European search report - dispatched on:EP02.03.2004
ClassificationIPC:A61K8/63, A61Q7/00, A61Q19/00, A61Q19/08
[2006/18]
CPC:
A61Q19/007 (EP); A61K8/63 (EP); A61P17/00 (EP);
A61P17/16 (EP); A61Q19/08 (EP); A61Q5/006 (EP);
A61Q7/00 (EP) (-)
Former IPC [2004/18]A61K7/48, A61P17/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/18]
TitleGerman:Verwendung von 5-Cholesten-3 beta,25-diol-7-on zur Behandlung trockener Haut oder Kopfhaut[2004/18]
English:Use of 5-Cholesten-3 beta,25-diol-7-one for the treatment of dry skin or scalp[2004/18]
French:Utilisation de la 5-cholesten-3 béta,25-diol-7-one pour le traitement des peaux sèches ou du cuir chevelu sec[2004/18]
Examination procedure28.10.2004Examination requested  [2004/53]
20.07.2005Despatch of a communication from the examining division (Time limit: M04)
05.08.2005Reply to a communication from the examining division
11.10.2005Communication of intention to grant the patent
21.02.2006Fee for grant paid
21.02.2006Fee for publishing/printing paid
Opposition(s)06.02.2007No opposition filed within time limit [2007/15]
Fees paidRenewal fee
12.10.2005Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.05.2006
CY03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
TR03.05.2006
BG03.08.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
LU10.10.2006
BE31.10.2006
MC31.10.2006
HU04.11.2006
[2009/38]
Former [2009/03]AT03.05.2006
CY03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
TR03.05.2006
BG03.08.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
LU10.10.2006
MC31.10.2006
HU04.11.2006
Former [2008/37]AT03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
TR03.05.2006
BG03.08.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
LU10.10.2006
MC31.10.2006
HU04.11.2006
Former [2008/32]AT03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
BG03.08.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
MC31.10.2006
HU04.11.2006
Former [2008/31]AT03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
BG03.08.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
MC31.10.2006
Former [2008/28]AT03.05.2006
CZ03.05.2006
EE03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
MC31.10.2006
Former [2008/21]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
GR04.08.2006
PT03.10.2006
MC31.10.2006
Former [2007/50]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
PT03.10.2006
MC31.10.2006
Former [2007/41]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
IT03.05.2006
NL03.05.2006
RO03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
PT03.10.2006
MC31.10.2006
Former [2007/40]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
IT03.05.2006
NL03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
PT03.10.2006
MC31.10.2006
Former [2007/19]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
NL03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
PT03.10.2006
Former [2007/13]AT03.05.2006
CZ03.05.2006
FI03.05.2006
IE03.05.2006
SI03.05.2006
SK03.05.2006
DK03.08.2006
SE03.08.2006
PT03.10.2006
Former [2006/52]AT03.05.2006
FI03.05.2006
SI03.05.2006
SE03.08.2006
Former [2006/48]SI03.05.2006
SE03.08.2006
Former [2006/40]SI03.05.2006
Documents cited:Search[AD]FR1255602  (WARNER LAMBERT PHARMACEUTICAL) [AD] 1-15 * page 4, column 1, lines 12,13 * * claims 1,2 * * page 1, column 1, line 1 - page 2, column 1, line 57 * * examples IX,X *;
 [AD]US4496556  (ORENTREICH NORMAN [US]) [AD] 1-15 * claim - * * column 4, lines 19-22 *;
 [AD]EP0608600  (UNILEVER PLC [GB], et al) [AD] 1-15 * page 2, lines 16-21 * * page 2, line 35 - page 3, line 14 * * page 7, lines 1-35 * * page 11, line 49 - page 12, line 8 * * claims 1,6,15,19 *;
 [AD]JPH09255552  (SHISEIDO CO LTD) [AD] 1-15 * claims 1-3,6 * * paragraphs [0002] - [0007] - [0010] - [0013] * * example - *;
 [AD]JPH11279018  (SHISEIDO CO LTD) [AD] 1-15 * claims 1,3 * * paragraphs [0002] - [0007] - [0010] , [0012] ** example - *;
 [XA]  - TAYLOR, FREDERICK R. ET AL, "Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase", JOURNAL OF BIOLOGICAL CHEMISTRY (1984), 259(20), 12382-7, XP001179506 [X] 9 * page 12382, column 2, paragraph 4 - page 12383, column 1, paragraph 2; figure 1 * * page 12387, column 1, lines 45-78 * [A] 1-8,10-15
 [A]  - MUGIKURA, SHIGERU ET AL, "Cosmetics containing keratinization inhibitors", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 127:336482, URL: STN, XP002248377 [A] 1-15 * abstract *
 [A]  - MARUYAMA, NAO ET AL, "Skin preparations containing keratin-softening agents and sequestering agents", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 131:276780, URL: STN, XP002248378 [A] 1-15 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.